Michael Page, MD
Colon & Rectal Surgery · Des Moines, IANPI 1295721223
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Covidien LP at 31.6% of the total. Reporting peaked in 2020 at $2,801 and has fallen 91.5% since, to $237 in 2025.
Across 85 payments — averaging $57.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$2K
- Baxter Healthcare$1K
- Medtronic$389
- Stryker$388
- AbbVie$261
- Merck$156
- plus $864 from 20 others
Across 1 payment — averaging $35,937 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$36K
What the payments were for
- Consulting fees$1,26026%
- Speaking & faculty fees$1,50031%
- Food & beverage$2,09543%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 4 | $1,536 |
| Baxter Healthcare | 1 | $1,260 |
| Medtronic | 9 | $389 |
| Stryker | 3 | $388 |
| AbbVie | 15 | $261 |
| Merck | 9 | $156 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $108 |
| Johnson & Johnson | 5 | $94 |
| Amgen | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 4 | $76 |
| Intuitive Surgical | 1 | $67 |
| Acera Surgical, Inc. | 2 | $55 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 1 | $27 |
| Boehringer Ingelheim | 1 | $25 |
| QOL Medical, LLC | 1 | $21 |
| Celltrion USA Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| Organon | 1 | $15 |
| Davol Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Gilead | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADEPT$1,260
- SEPRAFILM$1,260
- Signia$155
- SPY TECHNOLOGY$103
- 1588 HD 3 CHIP CAMERA$103
How this compares
Too few colon & rectal surgery providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 133 | $8,516 |
| Colestipol Hcl | 12 | $2,000 |
| CholestyramineCholestyramine (With Sugar) | 16 | $1,526 |
| Cholestyramine LightCholestyramine | 11 | $698 |
| Hydrocortisone | 30 | $342 |
| Neomycin Sulfate | 67 | $330 |
| Procto-Med HcHydrocortisone | 21 | $265 |
| Metronidazole | 81 | $158 |
| Ondansetron Hcl | 29 | $39 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Des Moines
- Ohmar CoughlinDes Moines$13K
- Alexander MenningDes Moines$8K
- Mayin LinDes Moines$6K
- Daniel OpheimDes Moines$3K
- Molly GrossDes Moines$2K
- Shankar RamanDes Moines$2K
- Soren KraemerDes Moines$468
- Muneera KapadiaIowa City$10K
- Kristina GuytonIowa City$6K
- Jennifer HrabeIowa City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.